tech providers
ANALYTICAL INSTRUMENTATION REGULATIONS TO BE KEY FOCUS AT INDIA LAB EXPO 2016
analytica Anacon India and India Lab Expo 2016, the annual trade fairs for analysis, laboratory and biotechnology return to the city of Hyderabad. Accompanying the trade fair, the analytica Anacon India and India Lab Expo conference is being held from October 20 to 21, 2016 at the Hitex Exhibition Center.
Regulatory aspects of Pharmaceutical Laboratories’,‘ Biopharmaceuticals and Bioanalysis’,‘ Food Safety’ or‘ Clinical Diagnosis’ are the main topics of the 2016 edition of the analytica Anacon India and India Lab Expo conference. The speakers, eminent scientists and industry representatives, come from both – India and overseas. The program is rounded out by tutorials in all four sessions where practical application tips are passed on the audience.
Among this year’ s speakers are Dr Laxmikant Gandikota( Biological Evans), Dr Ashes Ganguly( Indian Analytical Instruments Association), Prof Dr Myeong Hee Moon( Yonsei University), Prof Dr Michael Hilderbrand( University of Jena), Prof Dr Dietmar Knopp( Technical University of Munich), Prof Dr Rainer Lehmann( University of Tuebingen), Dr Eike Reich( CAMAG), Dr Pia Rosendahl( ISAS), Prof. Dr. Michael Rychlik( Technical University of Munich), Prof Oliver Schmitz( University of Duisburg-Essen), Arjan Timmerman( Waters Corporation) and Dr S P Vasireddi( Vimta Labs).
Mr Bhupinder Singh, CEO of Messe München India, commented:“ The conference will bring together leaders of this field to share a comprehensive overview of this rapidly expanding industry with the prime objective of knowledge transfer. Over 250 delegates will participate at the conference who will have the opportunity to interact with well-known scientists around the world. Participants can be sure of picking up important concepts, which will be very useful in the days to come.”
The organizers expect more than 350 exhibitors and 8,500 visitors to analytica Anacon India and India Lab Expo. Both trade fairs have been growing in stature as one of the most influential pit-stops in the Indian Annual
Trade Fair calendar. The two events bring together companies with similar product lines and business interests, apart from bringing the buyer and seller community on one common platform. The conference and various further forums will transmit additional momentum and background information on the various topics being deliberated at the trade fairs.
AVANTOR AND NUSIL TO MERGE, NEW ENTITY TO BE GLOBAL LEADER WITH $ 700 MILLION REVENUE
Avantor Performance Materials and NuSil Technology LLC, both portfolio companies of New Mountain Capital LLC, have signed a definitive agreement to merge. This merger will create the global leader in ultra-high-purity materials for the life sciences and advanced technology markets, as the demand for such materials grows due to technological advances, market expansion and the increasingly strict regulatory and performance specifications of the life sciences and other industries.
The combined company, to be named Avantor, will provide performance materials and solutions for the production and research needs of over 6,500 customers across the biotechnology, pharmaceutical, medical device, diagnostics, aerospace & defense, and semi-conductor industries. The combination brings complementary technologies and advanced analytical capabilities together to create a portfolio of over 30,000 products that meet increasingly stringent standards across technology-driven and highly-regulated markets. The company will be particularly well positioned to support the industrialization of the biopharmaceutical sector through its bioprocessing and biomaterials offerings with a focus on productivity and quality. Combined revenues will be over $ 700 million, growing at 14 % per year.
“ Avantor and NuSil both share a long-standing commitment to collaborate with customers to develop innovative products that meet the most stringent quality and regulatory standards,” said Michael Stubblefield, CEO of Avantor.“ Both companies have been highly successful and fast growing on their own, and together we will offer even more comprehensive product lines and technological advantages. We at Avantor look forward to working with the NuSil team to capture the full potential from this combination.”
“ We see significant growth opportunities resulting from the combined resources of Avantor and NuSil,” said Ernest Waaser, CEO of NuSil. " Both Avantor and New Mountain Capital share the same vision of creating the global sales and technology leader in ultra-high-purity materials for life sciences and advanced technology applications.”
Matt Holt, Managing Director at New Mountain Capital, said,“ Both Avantor and Nusil have transformed in very positive directions under New Mountain’ s ownership, with strong organic growth and attractive margins. The combined company will have strong positions across the drug lifecycle value chain including particular strengths in the bioprocessing and biomaterials segments, which we see as two highly attractive end markets that increasingly converge. We look forward to continuing to work with management to build the combined company.”
BIOVOICENEWS. COM 29